Eluvixtamab (AMG-330)
Revision as of 17:44, 3 February 2019 by Warner-admin (talk | contribs) (Text replacement - "Category:Investigational" to "Category:Investigational drugs")
Mechanism of action
Bispecific T-cell engager (BiTE) antibody that engages CD33 and CD3